The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Open accessAbstract
Objective: The main objective was to compare clinical features, disease course, and myelin oligodendrocyte glycoprotein (MOG) antibody (Ab) dynamics between children and adults with MOG‐Ab–associated disease (MOGAD). Methods: This retrospective multicentric, national study included 98 children and 268 adults with MOGAD between January 2014 and September 2019. Cox regression model for recurrent time‐to‐event data and Kaplan–Meier curves for time to antibody negativity were performed for the objectives. Results: Isolated optic neuritis was the most frequent clinical presentation in both children (40.8%) and adults (55.9%, p = 0.013), and acute disseminated encephalomyelitis syndrome was more frequent in children (36.7% vs 5.6%, p < 0.001). Compared to adults, children displayed better recovery (Expanded Disability Status Scale ≥ 3.0 at last follow‐up reached only by 10 of 97 [10.3%] vs 66/247 [26.7%], p < 0.001). In the multivariate analysis, adults were at higher risk of relapse than children (hazard ratio = 1.41, 95% confidence interval [CI] = 1.12–1.78, p = 0.003). At 2 years, 64.2% (95% CI = 40.9–86.5) of nonrelapsing children became MOG‐Ab negative compared to 14.1% (95% CI = 4.7–38.3) of relapsing children (log‐rank p < 0.001), with no differences observed in adults (log‐rank p = 0.280). Interpretation: MOGAD patients differ in the clinical presentation at onset, showing an age‐related shift in the clinical features across age groups. Compared to children, adults have a higher risk of relapse and worse functional recovery. Finally, children with monophasic disease become MOG‐Ab negative earlier than relapsing children, but this is not true in adults. Considering these differences, management and treatment guidelines should be considered independently in children and adults. ANN NEUROL 2021;89:30–41
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419 · cited 1×
“Differing from time-to-first-event analysis, which focuses on the first relapse and ignores subsequent events, Cox regression model for recurrent time-to-event data (Andersen–Gill model) was performed.(21) This model assumes that events increase along the time line and also that events are independent of each other fo…”
MethodDistinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000101 · Cited by 850
Clinical presentation and prognosis in MOG-antibody disease: a UK study
Jurynczyk, M., Messina, S., Woodhall, M. R., Raza, N., Everett, R., Roca-Fernandez, A., Tackley, G., Hamid, S., Sheard, A., Reynolds, G., et al. (2017) · Brain · doi:10.1093/brain/awx276 · Cited by 740
Ramanathan, S., Mohammad, S., Tantsis, E., Nguyen, T. K., Merheb, V., Fung, V. S. C., White, O. B., Broadley, S., Lechner-Scott, J., Vucic, S., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316880 · Cited by 572
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study
Cobo-Calvo, A., Ruiz, A., Maillart, E., Audoin, B., Zephir, H., Bourre, B., Ciron, J., Collongues, N., Brassat, D., Cotton, F., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005560 · Cited by 538
Self-citationIncreased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
Gorman, M. P., Healy, B. C., Polgar-Turcsanyi, M., & Chitnis, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.505 · Cited by 454
Hacohen, Y., Wong, Y. Y., Lechner, C., Jurynczyk, M., Wright, S., Konuskan, B., Kalser, J., Poulat, A. L., Maurey, H., Ganelin-Cohen, E., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4601 · Cited by 423
Self-citationLópez-Chiriboga, A. S., Majed, M., Fryer, J., Dubey, D., McKeon, A., Flanagan, E. P., Jitprapaikulsan, J., Kothapalli, N., Tillema, J.-M., Chen, J., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1814 · Cited by 410
Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome
Hennes, E.-M., Baumann, M., Schanda, K., Anlar, B., Bajer-Kornek, B., Blaschek, A., Brantner-Inthaler, S., Diepold, K., Eisenkölbl, A., Gotwald, T., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004312 · Cited by 341
Waters, P., Fadda, G., Woodhall, M., O’Mahony, J., Brown, R. A., Castro, D. A., Longoni, G., Irani, S. R., Sun, B., Yeh, E. A., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2940 · Cited by 335
Armangue, T., Olivé-Cirera, G., Martínez-Hernandez, E., Sepulveda, M., Ruiz-Garcia, R., Muñoz-Batista, M., Ariño, H., González-Álvarez, V., Felipe-Rucián, A., Jesús Martínez-González, M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30488-0 · Cited by 334
Self-citationBaumann, M., Sahin, K., Lechner, C., Hennes, E. M., Schanda, K., Mader, S., Karenfort, M., Selch, C., Hausler, M., Eisenkolbl, A., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308346 · Cited by 314
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
Pröbstel, A. K., Dornmair, K., Bittner, R., Sperl, P., Jenne, D., Magalhaes, S., Villalobos, A., Breithaupt, C., Weissert, R., Jacob, U., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c0b1 · Cited by 306
Höftberger, R., Sepulveda, M., Armangue, T., Blanco, Y., Rostásy, K., Cobo Calvo, A., Olascoaga, J., Ramió-Torrentà, L., Reindl, M., Benito-León, J., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514555785 · Cited by 285
Self-citationInternational multicenter examination of MOG antibody assays
Reindl, M., Schanda, K., Woodhall, M., Tea, F., Ramanathan, S., Sagen, J., Fryer, J. P., Mills, J., Teegen, B., Mindorf, S., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000674 · Cited by 284
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
Cobo-Calvo, A., Sepúlveda, M., Rollot, F., Armangué, T., Ruiz, A., Maillart, E., Papeix, C., Audoin, B., Zephir, H., Biotti, D., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1525-1 · Cited by 159
Self-citationClinical and MRI phenotype of children with MOG antibodies
Fernandez-Carbonell, C., Vargas-Lowy, D., Musallam, A., Healy, B. C., McLaughlin, K., Wucherpfennig, K. W., & Chitnis, T. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515587751 · Cited by 156
Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases
Hyun, J., Woodhall, M. R., Kim, S., Jeong, I. H., Kong, B. S., Kim, G., Kim, Y., Park, M. S., Irani, S. R., Waters, P. J., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315998 · Cited by 156
Duignan, S. M., Wright, S. K., Rossor, T., Cazabon, J., Gilmour, K. C., Ciccarelli, O., Wassmer, E., Lim, M. J., Hemingway, C. A., & Hacohen, Y. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13703 · Cited by 135
A population-based prospective study of optic neuritis
Soelberg, K. K., Jarius, S., Skejoe, H., Engberg, H., Mehlsen, J., Nilsson, A. C., Madsen, J. S., Reindl, M., Wildemann, B., Grauslund, J., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517734070 · Cited by 98
de Oliveira, L. M., Apóstolos‐Pereira, S. L., Pitombeira, M. S., Torretta, P. H. B., Callegaro, D., & Sato, D. K. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518811597 · Cited by 80
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
The OFSEP Group, Cobo‐Calvo, Á., The REEM Group, Sepúlveda, M., d’Indy, H., Armangué, T., Ruiz, A., Maillart, É., Papeix, C., Audoin, B., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-018-9160-9 · Cited by 69
Self-citationPediatric versus adult MS: similar or different?
Ghezzi, A., Baroncini, D., Zaffaroni, M., & Comi, G. (2017) · Multiple Sclerosis and Demyelinating Disorders · doi:10.1186/s40893-017-0022-6 · Cited by 59
Cobo‐Calvo, Á., Vukusic, S., & Marignier, R. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000681 · Cited by 47
Self-citationDeiva, K., Cobo‐Calvo, Á., Maurey, H., de Chalus, A., Yazbeck, E., Husson, B., Vukusic, S., Serguera, C., Horellou, P., Marignier, R., et al. (2020) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14594 · Cited by 34
Self-citation
Cited by
Banwell, B., Bennett, J. L., Marignier, R., Kim, H. J., Brilot, F., Flanagan, E. P., Ramanathan, S., Waters, P., Tenembaum, S., Graves, J. S., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00431-8 · Cited by 1,246
Self-citationMyelin-oligodendrocyte glycoprotein antibody-associated disease
Marignier, R., Hacohen, Y., Cobo-Calvo, A., Pröbstel, A.-K., Aktas, O., Alexopoulos, H., Amato, M.-P., Asgari, N., Banwell, B., Bennett, J., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00218-0 · Cited by 543
Self-citationSechi, E., Cacciaguerra, L., Chen, J. J., Mariotto, S., Fadda, G., Dinoto, A., Lopez-Chiriboga, A. S., Pittock, S. J., & Flanagan, E. P. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.885218 · Cited by 325
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment
Bennett, J. L., Costello, F., Chen, J. J., Petzold, A., Biousse, V., Newman, N. J., & Galetta, S. L. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00187-9 · Cited by 226
Metadata
- Authors
- Cobo‐Calvo, A., Ruiz, A., Rollot, F., Arrambide, G., Deschamps, R., Maillart, E., Papeix, C., Audoin, B., Lépine, A. F., Maurey, H., Zephir, H., Biotti, D., Ciron, J., Durand‐Dubief, F., Collongues, N., Ayrignac, X., Labauge, P., Meyer, P., Thouvenot, E., Bourre, B., Montcuquet, A., Cohen, M., Horello, P., Tintoré, M., De Seze, J., Vukusic, S., Deiva, K., Marignier, R., & the NOMADMUS, K.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2020-10-15
- Volume
- 89
- Issue
- 1
- Pages
- 30-41
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W3087282011
- Cited by
- 270
- References
- 25
- FWCI
- 15.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.